Shulph Ink
Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver Perspectives
Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver Perspectives
YOU SAVE £6.88
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver Perspectives
This book provides a comprehensive overview of rare disease drug development, offering insights from various perspectives and addressing key challenges and processes. It emphasizes the role of patient advocacy groups and advocates for improved clinical trials and market access strategies.
Format: Hardback
Length: 409 pages
Publication date: 09 November 2021
Publisher: Springer Nature Switzerland AG
This comprehensive book offers a thorough exploration of the intricate landscape of rare disease drug development, providing a diverse range of insights from a multitude of perspectives. It delves into the challenges faced by individuals living with rare diseases and their caregivers, emphasizing the critical role of patient advocacy groups in navigating the complexities of clinical trials and investment decisions. The book also sheds light on innovative approaches to clinical trial design and the optimization of rare disease registries. By examining the drug development processes across various disciplines, such as oncology, hematology, pediatrics, and gene therapy, it provides a comprehensive understanding of the complexities involved in bringing new treatments to patients with rare disorders. Furthermore, the book addresses the operational aspects of drug development, including regulatory approval processes, development accelerations, and market access strategies.
The authors argue for the importance of real-world data and evidence generation in orphan medicinal drug development, highlighting the need for more robust data to inform decision-making and improve patient outcomes.
Rare Disease Drug Development is an invaluable resource for biopharmaceutical R&D professionals, commercial experts, third-party capital providers, patient advocacy groups, patients, and caregivers seeking to gain a deeper understanding of the challenges and opportunities in rare disease drug development. Its comprehensive coverage, expert insights, and thoughtful analysis make it a must-read for anyone involved in this field.
Weight: 870g
Dimension: 160 x 241 x 23 (mm)
ISBN-13: 9783030786045
Edition number: 1st ed. 2021
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
